So do we have the prospect of GSK pushing a generic relenza into China whilst DS start a push in from Japan with Lani? Or is this not possible licensing wise?
CC9 Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings
SER How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign
Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back